X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse WYETH LTD with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs MYLAN (US) - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WYETH LTD   MYLAN
EQUITY SHARE DATA
    WYETH LTD
Mar-13
MYLAN
Dec-14
WYETH LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0444,053-   
Low Rs8182,856-   
Sales per share (Unadj.) Rs298.61,387.6-  
Earnings per share (Unadj.) Rs57.2167.2-  
Cash flow per share (Unadj.) Rs58.4269.1-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.5689.8-  
Shares outstanding (eoy) m22.72378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.12.5 125.3%   
Avg P/E ratio x16.320.7 78.7%  
P/CF ratio (eoy) x15.912.8 124.2%  
Price / Book Value ratio x3.75.0 74.5%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1571,307,233 1.6%   
No. of employees `0000.525.0 2.0%   
Total wages/salary Rs m4000-   
Avg. sales/employee Rs Th13,787.421,001.5 65.6%   
Avg. wages/employee Rs Th813.00-   
Avg. net profit/employee Rs Th2,643.32,530.0 104.5%   
INCOME DATA
Net Sales Rs m6,783525,037 1.3%  
Other income Rs m353-3,060 -11.5%   
Total revenues Rs m7,136521,977 1.4%   
Gross profit Rs m1,617130,579 1.2%  
Depreciation Rs m2738,562 0.1%   
Interest Rs m622,647 0.0%   
Profit before tax Rs m1,93866,310 2.9%   
Minority Interest Rs m0-272 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,788 22.7%   
Profit after tax Rs m1,30163,249 2.1%  
Gross profit margin %23.824.9 95.9%  
Effective tax rate %32.64.2 775.8%   
Net profit margin %19.212.0 159.1%  
BALANCE SHEET DATA
Current assets Rs m6,984461,577 1.5%   
Current liabilities Rs m2,056360,861 0.6%   
Net working cap to sales %72.619.2 378.7%  
Current ratio x3.41.3 265.6%  
Inventory Days Days9978 127.2%  
Debtors Days Days24107 22.3%  
Net fixed assets Rs m244121,466 0.2%   
Share capital Rs m22718,567 1.2%   
"Free" reserves Rs m5,4410-   
Net worth Rs m5,668260,995 2.2%   
Long term debt Rs m25389,901 0.0%   
Total assets Rs m7,9011,051,265 0.8%  
Interest coverage x353.33.9 8,995.3%   
Debt to equity ratio x01.5 0.3%  
Sales to assets ratio x0.90.5 171.9%   
Return on assets %16.58.2 202.3%  
Return on equity %22.924.2 94.7%  
Return on capital %34.013.6 249.9%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Net fx Rs m-2,6620-   
CASH FLOW
From Operations Rs m92369,017 1.3%  
From Investments Rs m317-54,428 -0.6%  
From Financial Activity Rs m-481-18,186 2.6%  
Net Cashflow Rs m759-3,598 -21.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 68.01 Rs / USD

Compare WYETH LTD With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WYETH LTD With: DISHMAN PHARMA  ALKEM LABORATORIES  TORRENT PHARMA  BIOCON LTD  GLENMARK PHARMA  



Today's Market

Indian Indices Trade in Red; US-China Trade War Back On; IPO Buzz and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened flat and ended the day in red. The S&P BSE Midcap Index ended down by 1% while S&P BSE Small Cap Index ended down by 1.3%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS